Vijaya Murthy, Rohan Willis, Zurina Romay-Penabad, Patricia Ruiz-Limón, Laura A Martínez-Martínez, Shraddha Jatwani, Praveen Jajoria, Alan Seif, Graciela S Alarcón, Elizabeth Papalardo, Jigna Liu, Luis M Vilá, Gerald McGwin, Terry A McNearney, Rashmi Maganti, Prashanth Sunkureddi, Trisha Parekh, Michael Tarantino, Ehtisham Akhter, Hong Fang, Emilio B Gonzalez, Walter R Binder, Gary L Norman, Zakera Shums, Marius Teodorescu, John D Reveille, Michelle Petri, Silvia S Pierangeli
OBJECTIVE: To examine the prevalence of isolated IgA anti-β2 -glycoprotein I (anti-β2 GPI) positivity and the association of these antibodies, and a subgroup that bind specifically to domain IV/V of β2 GPI, with clinical manifestations of the antiphospholipid syndrome (APS) in 3 patient groups and to evaluate the pathogenicity of IgA anti-β2 GPI in a mouse model of thrombosis. METHODS: Patients with systemic lupus erythematosus (SLE) from a multiethnic, multicenter cohort (LUpus in MInorities, NAture versus nurture [LUMINA]) (n = 558), patients with SLE from the Hopkins Lupus Cohort (n = 215), and serum samples referred to the Antiphospholipid Standardization Laboratory (APLS) (n = 5,098) were evaluated...
December 2013: Arthritis and Rheumatism